Learning Objectives

At the conclusion of this activity, participants should be better able to:
  • Explain how TPMT testing can be used to individualize therapy with thiopurines in inflammatory bowel disease (IBD)

  • Evaluate the role of therapeutic drug monitoring and laboratory testing (e.g., CBC) to guide dosing and assess for toxicity with thiopurines for IBD

  • Assess the limitations and strengths of the evidence that therapeutic drug monitoring can guide the optimization of anti-TNF therapy

  • Describe how to optimize the use measurement of anti-drug antibody levels and serum drug levels to guide management of patients currently receiving anti-TNF therapy

  • Provide appropriate care and counsel for patients and their families.